AI assistant
Sending…
ORAGENICS INC — Director's Dealing 2021
Feb 19, 2021
35380_dirs_2021-02-19_c5aa8806-e9c4-48c4-8ed8-2bbc25959b06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2021-02-18
Reporting Person: POPE CHARLES L (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-18 | Non-Employee Director Option (Right to Buy) | $1.20 | A | 160000 | Acquired | 2031-02-18 | Common Stock (160000) | Direct |
Footnotes
F1: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021.
More from ORAGENICS INC
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Jan 22
Capital/Financing Update
2026
Jan 22